Seth Klarman · Q3 2019
Baupost Group
Portfolio at the end of Q3 2019, from the 13F filed November 13, 2019. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Liberty Global LBTYK · history | 11.8% | Q3 2018 | Add 5% |
| Viasat VSAT · history | 11.7% | Q2 2013 or earlier | No change |
| Fox Corporation FOXA · history | 9.8% | Q1 2019 | No change |
| eBay EBAY · history | 7.3% | Q4 2018 | Reduce 31% |
| Cheniere Energy LNG · history | 7.2% | Q1 2014 | Reduce 5% |
| Bristol-Myers Squibb BMY · history | 5.7% | Q1 2019 | Reduce 23% |
| CBS CBS · history | 5.5% | Q4 2018 | Add 20% |
| Qorvo QRVO · history | 4.8% | Q1 2017 | Reduce 35% |
| Tesla TSLA.CV · convertible notes · history | 3.4% | Q1 2018 | No change |
| DigitalBridge CLNY · history | 3.4% | Q2 2018 | No change |
| PG&E PCG · history | 2.8% | Q1 2018 | No change |
| Nexstar Media Group NXST · history | 2.3% | Q4 2018 | Add 43% |
| Univar Solutions UNVR · history | 2.2% | Q3 2018 | No change |
| Liberty Global LBTYA · history | 2.1% | Q3 2018 | Add 3% |
| Theravance Biopharma TBPH · history | 2.1% | Q2 2014 | No change |
| Fox Corporation FOX · history | 2.0% | Q1 2019 | No change |
| McKesson MCK · history | 2.0% | Q3 2017 | Reduce 50% |
| Translate Bio TBIO · history | 2.0% | Q2 2018 | Add 98% |
| Synchrony SYF · history | 1.9% | Q3 2016 | Reduce 46% |
| Takeda Pharmaceutical TAK · history | 1.8% | Q1 2019 | No change |
| Nuance Communications NUAN · history | 1.5% | Q3 2019 | Buy |
| Atara Biotherapeutics ATRA · history | 1.3% | Q4 2014 | Add 19% |
| Cencora COR · history | 1.1% | Q3 2017 | Reduce 47% |
| Akebia Therapeutics AKBA · history | 1.1% | Q4 2018 | No change |
| Veritiv VRTV · history | 0.7% | Q3 2014 | No change |
| Antero Resources AR · history | 0.7% | Q3 2014 | Reduce 26% |
| Vista Energy VIST · history | 0.4% | Q3 2019 | Buy |
| Theravance Biopharma TBPH.CV · convertible notes · history | 0.3% | Q4 2016 | No change |
| Cars.com CARS · history | 0.3% | Q3 2019 | Buy |
| Trilogy Metals TMQ · history | 0.2% | Q2 2013 or earlier | Reduce 11% |
| Gossamer Bio GOSS · history | 0.2% | Q1 2019 | Reduce 24% |
| Paratek Pharmaceuticals PRTK · history | 0.1% | Q4 2014 | No change |
| 32 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q2 2019, adjusted for stock splits.
Sector weighting
| Media & telecom | 45.3% | |
|---|---|---|
| Health care | 17.7% | |
| Consumer discretionary | 10.8% | |
| Energy | 8.3% | |
| Technology | 6.6% | |
| Financials & real estate | 5.3% | |
| Industrials | 3.0% | |
| Utilities | 2.8% | |
| Materials | 0.2% |
What changed from Q2 2019
- Buy Nuance Communications NUAN 1.5% of the 13F
- Buy Vista Energy VIST 0.4% of the 13F
- Buy Cars.com CARS 0.3% of the 13F
- Add 5% Liberty Global LBTYK 10.1% → 11.8%
- Add 20% CBS CBS 4.5% → 5.5%
- Add 43% Nexstar Media Group NXST 1.3% → 2.3%
- Add 3% Liberty Global LBTYA 1.8% → 2.1%
- Add 98% Translate Bio TBIO 1.0% → 2.0%
- Add 19% Atara Biotherapeutics ATRA 1.3% → 1.3%
- Reduce 31% eBay EBAY 8.6% → 7.3%
- Reduce 5% Cheniere Energy LNG 6.6% → 7.2%
- Reduce 23% Bristol-Myers Squibb BMY 5.3% → 5.7%
- Reduce 35% Qorvo QRVO 5.2% → 4.8%
- Reduce 50% McKesson MCK 3.2% → 2.0%
- Reduce 46% Synchrony SYF 2.9% → 1.9%
- Reduce 47% Cencora COR 1.7% → 1.1%
- Reduce 26% Antero Resources AR 1.4% → 0.7%
- Reduce 11% Trilogy Metals TMQ 0.4% → 0.2%
- Reduce 24% Gossamer Bio GOSS 0.2% → 0.2%
- Sell Allergan AGN was 5.6%
- Sell XPO XPO was 0.8%
- Sell Sinclair SBGI was 0.3%